PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.69%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.73%
Negative gross profit growth while RUN is at 1.38%. Joel Greenblatt would examine cost competitiveness or demand decline.
-71.58%
Negative EBIT growth while RUN is at 94.94%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
104.85%
Operating income growth similar to RUN's 96.47%. Walter Schloss would assume both share comparable operational structures.
-82.70%
Negative net income growth while RUN stands at 101.78%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-83.87%
Negative EPS growth while RUN is at 101.76%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-99.76%
Negative diluted EPS growth while RUN is at 101.60%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
6.32%
Share count expansion well above RUN's 0.67%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
115.49%
Diluted share count expanding well above RUN's 14.68%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
89.72%
OCF growth above 1.5x RUN's 59.67%. David Dodd would confirm a clear edge in underlying cash generation.
89.76%
FCF growth above 1.5x RUN's 27.75%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-69.07%
Negative 10Y revenue/share CAGR while RUN stands at 255.40%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-61.18%
Negative 5Y CAGR while RUN stands at 26.01%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-48.88%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
96.18%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
96.92%
5Y OCF/share CAGR above 1.5x RUN's 53.05%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
94.77%
3Y OCF/share CAGR above 1.5x RUN's 62.54%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
239.80%
Net income/share CAGR 1.25-1.5x RUN's 197.30%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
1296.83%
5Y net income/share CAGR above 1.5x RUN's 194.19%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
153.46%
3Y net income/share CAGR 1.25-1.5x RUN's 129.46%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-109.80%
Negative equity/share CAGR over 10 years while RUN stands at 195.99%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-2088.09%
Negative 5Y equity/share growth while RUN is at 57.85%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-153.70%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
28.40%
AR growth well above RUN's 0.83%. Michael Burry fears inflated revenue or higher default risk in the near future.
-50.20%
Inventory is declining while RUN stands at 3.06%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.32%
Similar asset growth to RUN's 2.41%. Walter Schloss finds parallel expansions or investment rates.
14.20%
Positive BV/share change while RUN is negative. John Neff sees a clear edge over a competitor losing equity.
-7.07%
We’re deleveraging while RUN stands at 4.99%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-37.71%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.